Vinclozolin does not alter progesterone receptor (PR) function in vivo despite inhibition of PR binding by its metabolites in vitro

By Laws S.C.   Carey S.A.   Kelce W.R.   Cooper R.L.   Gray L.E.  

Toxicology, Vol. 112, Iss. 3, 1996-09 ,pp. : 173-182

Elsevier

Access to resources Recommend Favorite

Mode of Action: Impaired Fetal Leydig Cell Function—Effects on Male Reproductive Development Produced by Certain Phthalate Esters

By Foster Paul  

Critical Reviews in Toxicology, Vol. 35, Iss. 8-9, 2005-10 ,pp. : 713-719

Informa Healthcare

Access to resources Recommend Favorite

Vinclozolin andp,p'-DDE Alter Androgen-Dependent Gene Expression:In VivoConfirmation of an Androgen Receptor-Mediated Mechanism

By Kelce W.R.   Lambright C.R.   Gray L.E.   Roberts K.P.  

Toxicology and Applied Pharmacology, Vol. 142, Iss. 1, 1997-01 ,pp. : 192-200

Elsevier

Access to resources Recommend Favorite

Mode of Action: Reduction of Testosterone Availability—Molinate-Induced Inhibition of Spermatogenesis

By Kavlock Robert   Cummings Audrey  

Critical Reviews in Toxicology, Vol. 35, Iss. 8-9, 2005-10 ,pp. : 685-690

Informa Healthcare

Access to resources Recommend Favorite

Comparison of antiandrogenic activities of vinclozolin and d,l-camphorquinone in androgen receptor gene transcription assay in vitro and mouse in utero exposure assay in vivo

By Shimamura M.   Kodaira K.   Kenichi H.   Ishimoto Y.   Tamura H.   Iguchi T.  

Toxicology, Vol. 174, Iss. 2, 2002-05 ,pp. : 97-107

Elsevier

Access to resources Recommend Favorite